Medscape

Rivaroxaban Is Superior to Enoxaparin for Thromboprophylaxis After Knee and Hip Arthroplasty

The results of three studies could usher in a new era of fixed-dose oral thromboprophylaxis. Prophylactic anticoagulation is recommended practice following total knee and hip arthroplasty. Commonly ...
Healio

RE-NOVATE II: Dabigatran superior to enoxaparin after total hip replacement

Please provide your email address to receive an email when new articles are posted on . Extended prophylaxis with the oral anticoagulant dabigatran was superior in efficacy to subcutaneous enoxaparin ...
Healio

Edoxaban prevents VTE better than enoxaparin after total hip arthroplasty

Oral edoxaban showed superior results to subcutaneous enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty, according to findings published in Thrombosis Journal. “In ...
Medscape

RE-NOVATE 2: Dabigatran "noninferior" to enoxaparin for VTE-event prophylaxis in setting of hip surgery

Barcelona, Spain - In a randomized trial of patients undergoing total hip-replacement surgery, the oral anticoagulant dabigatran (Boehringer Ingelheim) was at least as effective as subcutaneous ...
FierceBiotech

ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Preve

ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior to Enoxaparin in the Prevention of Venous Thromboembolism Following Knee Replacement Surgery Phase ...
Monthly Prescribing Reference

Rivaroxaban Found Noninferior to Enoxaparin in Acutely Ill

(HealthDay News) – In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration ...
TCTMD

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Oral rivaroxaban (Xarelto; Bayer/Janssen) is superior to subcutaneous enoxaparin in preventing venous thromboembolism (VTE) without increasing bleeding in patients undergoing nonmajor orthopedic ...
FierceBiotech

In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent

In the Prevention of VTE in Acutely ill Patients, Rivaroxaban Compares Favorably with Enoxaparin but Does Not Show a Consistent Net Clinical Benefit MAGELLAN study meets primary efficacy endpoints of ...
Monthly Prescribing Reference

Enoxaparin Doesn’t Reduce Death Rate for Acutely Ill

HealthDay News— For hospitalized, acutely ill medical patients, use of enoxaparin plus elastic stockings with graduated compressions, does not reduce the rate of death from any cause at 30 days, ...
Medindia

How to Take Enoxaparin and it's Dose

For preventing DVT in abdominal surgery, it is given as 40 mg subcutaneous once daily up to 12 days. It is recommended to be given as 30 mg SC every 12 hours up to 14 days DVT prophylaxis in hip and ...
Fierce Healthcare

Newly Published Investigational Apixaban ADVANCE-3 Study Results Demonstrate Statistical Superiority to Enoxaparin with Co

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the ADVANCE-3 study results, published in The New England ...